Poster Session, PAGANZ Sydney 2021 Virtual Meeting
Event Information
About this Event
We invite you to attend the PAGANZ Sydney 2021 Virtual Meeting.
The annual Population Approach Group in Australia and New Zealand (PAGANZ) meeting will be the first virtual PAGANZ meeting hosted in Sydney, Australia by the school of Pharmacy, University of Sydney; St Vincent’s Hospital, Sydney and St Vincent’s Clinical School, UNSW from Wednesday 27th January to Friday 29th January 2021.
When: Wednesday 27th January to Friday 29th January 2021 (Sydney, Australia time (AEDT))
Registration: https://www.paganz.org/register/
Poster Session
Chaired by: Dr Shaun Kumar
Friday, 29th January 2021, 1200 – 1400 AEDT
1200-1205 AEDT Sima Sadrai Population Pharmacokinetics Modeling of Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) Sima Sadrai
1205-1210 AEDT Sudeep Pradhan Evaluation of the intact nephron hypothesis using optimal design methodology
1210-1215 AEDT Shengjie Zhang Pharmacokinetic modelling for remdesivir
1215-1220 AEDT James D Morse A Universal Pharmacokinetic Model for Dexmedetomidine in Children and Adults
1220-1225 AEDT Abdallah Derbalah QSP Model Simplification Using Machine Learning with an Application to Heparin Dose-Response in Children
1225-1230 AEDT Rachael Hickey Toward an in silico viral kinetic model for Covid-19 with pharmacodynamic effects
1230-1235 AEDT Jian Lynn Lee Impact of genetic and non-genetic factors on the pharmacokinetics of intravenous immunoglobulin in patients with predominantly antibody deficiencies in Malaysia
1235-1240 AEDT Mohamed Tarek Analysis of Laplace Approximation for Pharmaceutical Nonlinear Mixed Effects Models
1240-1245 AEDT Akosua A. Agyeman Mechanism-based modelling of meropenem plus tobramycin combination regimens against clinical hypermutable Pseudomonas aeruginosa in the hollow-fibre infection model
1245-1250 AEDT Guangda Ma External Evaluation of Vancomycin Models
1250-1255 AEDT Estelle Yau Physiologically-based pharmacokinetic (PBPK) models for translation of drug distribution from rat to human
1255-1300 AEDT Liang Yang A mathematical model of CB1 receptor allosteric modulation
1300-1305 AEDT Conor O'Hanlon An ex vivo study measuring antibiotic adsorption to cardiopulmonary bypass circuitry
1305-1310 AEDT Pieter Van Brantegem A population pharmacokinetic model of sildenafil in an extra-uterine system for premature lambs
1310-1315 AEDT Laurynas Mockeliunas A Population Pharmacokinetic Model of Linezolid enabling Model-Informed Precision Dosing in Patients with Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
1315-1320 AEDT Dala N Daraghmeh Association between seropositivity and remission in rheumatoid arthritis patients receiving disease-modifying antirheumatic drugs: a retrospective analysis of 5 phase III randomized clinical trials of tocilizumab
1320-1325 AEDT Sebastian Rosser Population pharmacokinetics of dimethylacetamide in children receiving intravenous busulphan
1325-1330 AEDT Alejandra Schiavo Prediction of multiple-dose relative bioavailability outcome for an extended release valproic acid formulation
1330-1335 AEDT Valentina Topić Vučenović The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach
